Dr. Alan Roth, CEO of Oxford Drug Design, has a diverse background in life sciences spanning research, capital markets, consultancy, and company leadership. He began as a chemist at Merck in New Lead Discovery, later serving as a consultant at McKinsey and Director at Commerzbank Asset Management overseeing bio-investments. He co-founded and led Chiral Quest, Inc., and was a Royal Society Entrepreneur in Residence at Oxford, where he is also a Visiting Lecturer. He holds degrees from Cornell, Columbia, and Oxford.
LinkedIn: https://www.linkedin.com/in/alandroth/?originalSubdomain=uk
Website: http://www.oxforddrugdesign.com/
LinkedIn: https://www.linkedin.com/in/flor-laorga/
X: https://x.com/florlaorga
Website: https://aifn.co/flor
Website: https://aifn.co
LinkedIn: https://www.linkedin.com/company/ai-frontier-network/
X: https://x.com/aifn_co
YouTube: https://www.youtube.com/@ai-frontier-network
00:00 Start
00:25 Meet Dr. Alan Roth, Life Sciences Entrepreneur
00:56 From Academic Chemist to Industry Leader
04:53 How AI Advances Drug Discovery Processes
13:00 Overcoming Hurdles in Biotech Innovation
24:14 Balancing AI and Human Insight in R&D
30:46 Lessons for Future Scientists and Entrepreneurs
32:43 Staying Human in a High-Tech Future